Kou Katayama

Specificity of antibodies to type II collagen in rheumatoid arthritis

Kuniaki Terato, Yasunori Shimozuru, Kou Katayama et al. · Arthritis & Rheumatism · 1990 · 185 citations

Life Sciences, Immunology, Pathology +14

Efficacy and safety of peficitinib (ASP015K) in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase III randomised, double-blind, placebo-controlled trial (RAJ4) in Japan

Tsutomu Takeuchi, Yoshiya Tanaka, Sakae Tanaka et al. · Annals of the Rheumatic Diseases · 2019 · 130 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Safety and efficacy of combination therapy of iguratimod with methotrexate for patients with active rheumatoid arthritis with an inadequate response to methotrexate: An open-label extension of a randomized, double-blind, placebo-controlled trial

Masako Hara, Naoki Ishiguro, Kou Katayama et al. · Modern Rheumatology · 2013 · 70 citations

Medicine, Clinical Sciences, Pharmacotherapy +14

Effects of an Oral Administration of Glucosamine-Chondroitin-Quercetin Glucoside on the Synovial Fluid Properties in Patients with Osteoarthritis and Rheumatoid Arthritis

Hiroaki Matsuno, Hiroshi Nakamura, Kou Katayama et al. · Bioscience Biotechnology and Biochemistry · 2009 · 61 citations · Full text

Medicine, Clinical Sciences, Nutritional Sciences +17

Concomitant iguratimod therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate: a randomized, double-blind, placebo-controlled trial

Naoki Ishiguro, Kazuhiko Yamamoto, Kou Katayama et al. · Modern Rheumatology · 2013 · 56 citations

Medicine, Clinical Sciences, Pharmacotherapy +9